Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Stimulant and non-stimulant drugs can reduce symptoms of attention deficit/hyperactivity disorder (ADHD). The stimulant drug methylphenidate (MPH) and the non-stimulant drug atomoxetine (ATX) are both widely used for ADHD treatment, but their differential effects on human brain function remain unclear. We combined event-related fMRI with multivariate pattern recognition to characterize the effects of MPH and ATX in healthy volunteers performing a rewarded working memory (WM) task. The effects of MPH and ATX on WM were strongly dependent on their behavioral context. During non-rewarded trials, only MPH could be discriminated from placebo (PLC), with MPH producing a similar activation pattern to reward. During rewarded trials both drugs produced the opposite effect to reward, that is, attenuating WM networks and enhancing task-related deactivations (TRDs) in regions consistent with the default mode network (DMN). The drugs could be directly discriminated during the delay component of rewarded trials: MPH produced greater activity in WM networks and ATX produced greater activity in the DMN. Our data provide evidence that: (1) MPH and ATX have prominent effects during rewarded WM in task-activated and -deactivated networks; (2) during the delay component of rewarded trials, MPH and ATX have opposing effects on activated and deactivated networks: MPH enhances TRDs more than ATX, whereas ATX attenuates WM networks more than MPH; and (3) MPH mimics reward during encoding. Thus, interactions between drug effects and motivational state are crucial in defining the effects of MPH and ATX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954 · cited 2×
“We embedded all classifiers contrasting reward or drug state in a recursive feature elimination framework (RFE; Guyon et al., 2002), which is a backward elimination feature selection approach that aims to find a parsimonious set of features (voxels) by iteratively removing the least informative features.”
MethodWillcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568
Beyond mind-reading: multi-voxel pattern analysis of fMRI data
Norman, K. A., Polyn, S. M., Detre, G. J., & Haxby, J. V. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.07.005 · Cited by 2,271
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Common blood flow changes across visual tasks: II. Decreases in cerebral cortex
Shulman, G. L., Fiez, J. A., Corbetta, M., Buckner, R. L., Miezin, F. M., Raichle, M. E., & Petersen, S. E. (1997) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1997.9.5.648 · Cited by 1,890 · cited 2×
“The PCC, precuneus and ventromedial PFC are known to show decreased activity during a wide range of goal-directed tasks (Shulman et al., 1997).”
BackgroundUncertainty, Neuromodulation, and Attention
Yu, A. J., & Dayan, P. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.026 · Cited by 1,774 · cited 2×
“NA is also known to increase delay-related activity of PFC neurons in response to ‘signals’ (Arnsten, 2007) and increase the salience of novel stimuli, leading to the suggestion that it serves as an alarm system for contextual changes (Yu and Dayan, 2005).”
BackgroundThe neural bases of momentary lapses in attention
Weissman, D. H., Roberts, K. C., Visscher, K. M., & Woldorff, M. G. (2006) · Nature Neuroscience · doi:10.1038/nn1727 · Cited by 1,566 · cited 2×
“Indeed, failure to suppress default mode activity reflects momentary lapses in attention (Weissman et al., 2006) resulting in increased probability of error (Eichele et al., 2008).”
BackgroundCognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500 · cited 2×
“…(WM) - the ability to hold and manipulate information for future action - is impaired in ADHD (Martinussen et al., 2005; Willcutt et al., 2005) and has been strongly linked to the activity of the catcholamines (DA and NA) within the PFC (Brozoski et al., 1979; Arnsten and Goldman-Rakic, 1985).”
BackgroundInfluentialMARTINUSSEN, R., HAYDEN, J., HOGG-JOHNSON, S., & TANNOCK, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153228.72591.73 · Cited by 1,297 · cited 11×
“Stimulant and non-stimulant drugs can reduce symptoms of attention deficit/hyperactivity disorder (ADHD).”
BackgroundInfluentialSchultz, W., Apicella, P., & Ljungberg, T. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-00900.1993 · Cited by 1,291
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013 · cited 2×
“Historically, DA has been linked with WM performance through increasing the efficiency of PFC neurons by decreasing delay related response Marquand et al. Page 17 of 31 to “noise” (Arnsten, 2007; Vijayraghavan et al., 2007) and the stabilisation of their sustained activity (Durstewitz et al., 2000).”
BackgroundMattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · cited 2×
“In particular, genetic factors influence responses to stimulants (Mattay et al., 2003) and although we did not collect genetic information here, inclusion of genetic factors can only be expected to improve predictive performance.”
BackgroundMichelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · cited 4×
“However, NA is probably also important as therapeutic doses of MPH increase PFC extracellular concentrations of NA substantially more than DA (Berridge et al., 2006), and the beneficial effects of MPH and ATX on WM can be blocked by either DA D1 or NA α2 receptor antagonists (Arnsten and Dudley, 2005; Gamo et al.”
BackgroundInfluentialMehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608 · cited 4×
“However, previous studies using MPH and amphetamine have suggested that reductions in BOLD activation accompanied by equivalent behavioural performance reflect an increased efficiency of WM networks (Mattay et al., 2000; Mehta et al., 2000).”
BackgroundResultInfluentialSelf-citationWho “Is Saying What”? Brain-based decoding of human voice and speech
Formisano, E., De Martino, F., Bonte, M., & Goebel, R. (2008) · Science · doi:10.1126/science.1164318 · Cited by 599 · cited 2×
“Half the trials carried a monetary reward, indicated by the colour of the stimulus and the order of trials was randomised and counterbalanced across participants.”
MethodArnsten, A. F. T., & Goldman-Rakic, P. S. (1985) · Science · doi:10.1126/science.2999977 · Cited by 549 · cited 1×
“…(WM) - the ability to hold and manipulate information for future action - is impaired in ADHD (Martinussen et al., 2005; Willcutt et al., 2005) and has been strongly linked to the activity of the catcholamines (DA and NA) within the PFC (Brozoski et al., 1979; Arnsten and Goldman-Rakic, 1985).”
BackgroundBidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons
Seamans, J. K., Gorelova, N., Durstewitz, D., & Yang, C. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03628.2001 · Cited by 507 · cited 2×
“This effect is probably mediated by increased catecholamine concentrations in WM regions (Bymaster et al., 2002), which is known to focus neuronal activity by enhancing responses to task-relevant stimuli while suppressing background noise (Foote et al., 1975; Seamans et al., 2001).”
BackgroundStimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473 · cited 4×
“Catecholaminergic signalling has also been associated with an ‘inverted-U’ dose-response relationship in the PFC (Arnsten, 2006; Levy, 2009) with optimal PFC function at intermediate concentrations and too much or too little DA or NA resulting in impaired PFC function.”
BackgroundInfluentialEffects of putative neurotransmitters on neuronal activity in monkey auditory cortex
Foote, S. L., Freedman, R., & Oliver, A. P. (1975) · Brain Research · doi:10.1016/0006-8993(75)90699-x · Cited by 458 · cited 2×
“This effect is probably mediated by increased catecholamine concentrations in WM regions (Bymaster et al., 2002), which is known to focus neuronal activity by enhancing responses to task-relevant stimuli while suppressing background noise (Foote et al., 1975; Seamans et al., 2001).”
BackgroundEffects of methylphenidate on spatial working memory and planning in healthy young adults
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050284 · Cited by 389
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 3×
“…to have consistently greater clinical efficacy than atomoxetine (ATX), a non-stimulant drug recently approved for the treatment of ADHD in the USA and Europe (Spencer et al., 1998; Michelson et al., 2001; Faraone et al., 2005; Kemner et al., 2005; Starr and Kemner, 2005; Newcorn et al., 2008).”
BackgroundSchultz, W., & Romo, R. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.63.3.607 · Cited by 334 · cited 2×
“, 1993)and increased dopaminergic firing, often followed by immediate depression, is also associated with stimuli that resemble the rewarded stimulus (Schultz and Romo, 1990).”
BackgroundA lack of default network suppression is linked to increased distractibility in ADHD
Fassbender, C., Zhang, H., Buzy, W. M., Cortes, C. R., Mizuiri, D., Beckett, L., & Schweitzer, J. B. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.070 · Cited by 316
Effects of dextroamphetamine on cognitive performance and cortical activation
Mattay, V. S., Callicott, J. H., Bertolino, A., Heaton, I., Frank, J. A., Coppola, R., Berman, K. F., Goldberg, T. E., & Weinberger, D. R. (2000) · NeuroImage · doi:10.1006/nimg.2000.0610 · Cited by 296 · cited 2×
“However, previous studies using MPH and amphetamine have suggested that reductions in BOLD activation accompanied by equivalent behavioural performance reflect an increased efficiency of WM networks (Mattay et al., 2000; Mehta et al., 2000).”
BackgroundResultKelly, C., de Zubicaray, G., Di Martino, A., Copland, D. A., Reiss, P. T., Klein, D. F., Castellanos, F. X., Milham, M. P., & McMahon, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0810-09.2009 · Cited by 292 · cited 2×
“, 1986) and there is emerging evidence suggesting that the striatal DA system plays a role in the modulation of the DMN (Kelly et al., 2009; Tomasi et al., 2009).”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281 · cited 1×
“The pattern favouring MPH was restricted to encoding and was localised mostly to the cerebellum and lateral PFC. [Figure 5 about here] Marquand et al. Page 14 of 31”
BackgroundEmbedding reward signals into perception and cognition
Pessoa, L. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00017 · Cited by 279 · cited 4×
“This may be because the WM task we employed does not substantially engage the striatum, even for rewarded trials (Supplementary Figure S2), which is consistent with a recent review of the effects of reward on WM (Pessoa and Engelmann, 2010) or simply because the consequential effects of MPH on striatal DA levels are e…”
BackgroundResultInfluentialPeterson, B. S., Potenza, M. N., Wang, Z., Zhu, H., Martin, A., Marsh, R., Plessen, K. J., & Yu, S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08050724 · Cited by 261
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Gamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232 · cited 5×
“…also important as therapeutic doses of MPH increase PFC extracellular concentrations of NA substantially more than DA (Berridge et al., 2006), and the beneficial effects of MPH and ATX on WM can be blocked by either DA D1 or NA α2 receptor antagonists (Arnsten and Dudley, 2005; Gamo et al., 2010).”
BackgroundInfluentialA functional neuroimaging study of motivation and executive function
Taylor, S. F., Welsh, R. C., Wager, T. D., Luan Phan, K., Fitzgerald, K. D., & Gehring, W. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.10.032 · Cited by 222 · cited 2×
“The pattern favouring MPH was restricted to encoding and was localised mostly to the cerebellum and lateral PFC. [Figure 5 about here] Marquand et al. Page 14 of 31”
BackgroundArnsten, A. F. T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm033 · Cited by 200
Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects
ANDREOU, P., NEALE, B. M., CHEN, W., CHRISTIANSEN, H., GABRIELS, I., HEISE, A., MEIDAD, S., MULLER, U. C., UEBEL, H., BANASCHEWSKI, T., et al. (2007) · Psychological Medicine · doi:10.1017/s0033291707000815 · Cited by 182 · cited 9×
“Stimulant and non-stimulant drugs can reduce symptoms of attention deficit/hyperactivity disorder (ADHD).”
BackgroundInfluentialTomasi, D., Volkow, N. D., Wang, R., Telang, F., Wang, G.-J., Chang, L., Ernst, T., & Fowler, J. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006102 · Cited by 154
Schweitzer, J. B., Lee, D. O., Hanford, R. B., Zink, C. F., Ely, T. D., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.011 · Cited by 135
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108
Kemner, J. E., Starr, H. L., Ciccone, P. E., Hooper-Wood, C. G., & Crockett, R. S. (2005) · Advances in Therapy · doi:10.1007/bf02849870 · Cited by 99 · cited 1×
“…to have consistently greater clinical efficacy than atomoxetine (ATX), a non-stimulant drug recently approved for the treatment of ADHD in the USA and Europe (Spencer et al., 1998; Michelson et al., 2001; Faraone et al., 2005; Kemner et al., 2005; Starr and Kemner, 2005; Newcorn et al., 2008).”
BackgroundGilbert, D. L., Ridel, K. R., Sallee, F. R., Zhang, J., Lipps, T. D., & Wassermann, E. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300806 · Cited by 97
Gibbs, S. E. B., & D'Esposito, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0077-5 · Cited by 88
Cited by
A Review of Feature Reduction Techniques in Neuroimaging
Mwangi, B., Tian, T. S., & Soares, J. C. (2014) · Neuroinformatics · doi:10.1007/s12021-013-9204-3 · Cited by 559
Chu, C., Hsu, A.-L., Chou, K.-H., Bandettini, P., & Lin, C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.066 · Cited by 319
Cognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 298
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164
“However, additional evidence indicates that clinically-relevant doses of psychostimulants exert a more complex pattern of actions on frontostriatal activity that are task, region, and hemisphere-dependent (13,71-74).”
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies
Linssen, A. M. W., Sambeth, A., Vuurman, E. F. P. M., & Riedel, W. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001594 · Cited by 159
“Two fMRI studies on working memory showed increased activation of the dorsal attention network and altered default mode network activation with MPH (Marquand et al., 2011; Tomasi et al., 2011), suggesting that MPH may exert its effects on cognition partly by modulating the default mode network.”
Background
Metadata
- Authors
- Marquand, A. F., De Simoni, S., O'Daly, O. G., Williams, S. C., Mourão-Miranda, J., & Mehta, M. A.
- Venue
- Neuropsychopharmacology
- Published
- 2011-02-23
- Volume
- 36
- Issue
- 6
- Pages
- 1237-1247
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2048513666
- Cited by
- 95
- References
- 42
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.